Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
Nest Genomics (YC W22) has raised $8.5M in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Nest Genomics (YC W22)'s investors include Alumni Ventures, B Capital, Y Combinator, Samsung NEXT, Pioneer Fund.
Nest Genomics (YC W22) is headquartered in New York, United States.
Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
Nest Genomics (YC W22) is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nest Genomics (YC W22) — Funding & Investors." VCBacked, January 10, 2023, https://www.vcbacked.co/company/nest-genomics-yc-w22. Accessed July 20, 2026.
VCBacked. (2023). Nest Genomics (YC W22) — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nest-genomics-yc-w22
{{cite web |title=Nest Genomics (YC W22) — Funding & Investors |url=https://www.vcbacked.co/company/nest-genomics-yc-w22 |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated